Aurobindo Pharma shares advanced as much as 4.32 per cent on Tuesday after the company posted a jump of 39.39 per cent in its consolidated net profit figures at Rs 562.85 crore for the quarter ended March 31, 2016
Aurobindo Pharma has received final nod from the US health regulator to manufacture and market its anaesthetic Bupivacaine Hydrochloride injection in the American market.
Aurobindo Pharma has received approval from the US health regulator to sell generic Zolmitriptan tablets, a drug used to treat migraine, in the American market.
Aurobindo Pharma has received final approval from the USFDA to manufacture and market Fenofibrate tablets, used for the treatment of high level of cholesterol, in the American market.
Aurobindo Pharma shares advanced over 4 per cent on Tuesday after the pharma company announced that it has received USFDA approval for its epilepsy prevention drug Lacosamide
Maruti Suzuki shares closed 2.94 per cent down at Rs 3748.45 after Japense yen soared almost 3 per cent against the dollar and euro as the Bank of Japan opted out of any further moves to ease policy.
Aurobindo Pharma today said it has received final approval from the US health regulator to manufacture and market generic version of blood pressure treatment drugs Amlodipine and Valsartan tablets
Valganciclovir tablets is an anti-viral used in the treatment of Cytomegalovirus (CMV) retinitis Aurobindo Pharma received final approval from the US Food & Drug Administration (US FDA) to manufacture and market valgancic
Aurobindo Pharma shares gained over 3 per cent on Monday after it announced that the company has received final approval from USFDA to manufacture and market Naproxen Sodium Tablets
VA Tech Wabag stocks settled 4.85 per cent up at Rs 533.20 after the company informed stock exchanges that it has bagged record orders worth Rs 5,000 crore in FY 2016.
The company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Voriconazole tablets in the strengths of 50 mg and 200 mg, Aurobindo Pharma said in a statement.
